AU1201801A - Treatment of dermal tumors, warts, and viral infections using heat-killed p. acnes - Google Patents

Treatment of dermal tumors, warts, and viral infections using heat-killed p. acnes

Info

Publication number
AU1201801A
AU1201801A AU12018/01A AU1201801A AU1201801A AU 1201801 A AU1201801 A AU 1201801A AU 12018/01 A AU12018/01 A AU 12018/01A AU 1201801 A AU1201801 A AU 1201801A AU 1201801 A AU1201801 A AU 1201801A
Authority
AU
Australia
Prior art keywords
acnes
warts
killed
treatment
heat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU12018/01A
Inventor
Bobby G. Edwards
Kent R. Van Kampen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Van Kampen Group Inc
Original Assignee
Van Kampen Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Van Kampen Group Inc filed Critical Van Kampen Group Inc
Publication of AU1201801A publication Critical patent/AU1201801A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
AU12018/01A 1999-10-15 2000-10-13 Treatment of dermal tumors, warts, and viral infections using heat-killed p. acnes Abandoned AU1201801A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15956799P 1999-10-15 1999-10-15
US60159567 1999-10-15
PCT/US2000/028361 WO2001054727A1 (en) 1999-10-15 2000-10-13 Treatment of dermal tumors, warts, and viral infections using heat-killed p. acnes

Publications (1)

Publication Number Publication Date
AU1201801A true AU1201801A (en) 2001-08-07

Family

ID=22573102

Family Applications (1)

Application Number Title Priority Date Filing Date
AU12018/01A Abandoned AU1201801A (en) 1999-10-15 2000-10-13 Treatment of dermal tumors, warts, and viral infections using heat-killed p. acnes

Country Status (5)

Country Link
EP (1) EP1220688A1 (en)
AU (1) AU1201801A (en)
CA (1) CA2383626A1 (en)
MX (1) MXPA02003742A (en)
WO (1) WO2001054727A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
EP2298311B1 (en) 1999-01-13 2012-05-09 Bayer HealthCare LLC w-Carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
MXPA04007832A (en) 2002-02-11 2005-09-08 Bayer Pharmaceuticals Corp Aryl ureas with angiogenesis inhibiting activity.
CA2526617C (en) 2003-05-20 2015-04-28 Bayer Pharmaceuticals Corporation Diaryl ureas with kinase inhibiting activity
UA84156C2 (en) 2003-07-23 2008-09-25 Байер Фармасьютикалс Корпорейшн Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
AU2005326226B2 (en) 2005-01-31 2010-11-11 Eci, Inc. Immunopotentiating agent
EP2455092A1 (en) * 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect against upper respiratory tract infections
CN117511758A (en) * 2022-08-04 2024-02-06 复旦大学附属华山医院 Propionibacterium acnes, uses, compositions and medicaments thereof
CN115317520B (en) * 2022-09-06 2024-04-05 浙江大学 Zinc-aluminum hydrotalcite-like compound-propionibacterium acnes bacterial hybrid material and preparation method and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4479935A (en) * 1980-04-22 1984-10-30 Institut Pasteur Fractions extracted from aerobic bacteria, endowed with antitumoral, antibacterial and interferon inducing properties, and process for their preparation
JPS59161320A (en) * 1983-03-04 1984-09-12 Maruyama Chisato Lipopolysaccharide and its preparation

Also Published As

Publication number Publication date
MXPA02003742A (en) 2003-10-14
EP1220688A1 (en) 2002-07-10
WO2001054727A1 (en) 2001-08-02
CA2383626A1 (en) 2001-08-02

Similar Documents

Publication Publication Date Title
AU3957600A (en) Piperidyl-imidazole derivatives, their preparations and therapeutic uses
AU3885801A (en) Magnetically guided myocardial treatment system
AU6549898A (en) Method for the broad based treatment of infections, especially infections of organs such as the skin and vagina
MX264033B (en) Enzyme treatment for infection.
AU1392900A (en) 2,5-diazabicyclo(2.2.1)heptane derivatives, their preparation and therapeutic uses
ZA200202822B (en) Oncolytic combinations for the treatment of cancer.
AU2001294834A1 (en) Recombinant bcg vaccines for the prevention and treatment of cancer
AU6246199A (en) Human interleukin-b50, therapeutic uses
WO2001055111A8 (en) Biaryl compounds, their preparation and their use in therapy
AU1201801A (en) Treatment of dermal tumors, warts, and viral infections using heat-killed p. acnes
AU7748200A (en) Hypoxia-related human genes, proteins, and uses thereof
HK1033671A1 (en) Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses.
AU2002220280A1 (en) Polynuclear complex fe(iii) with pullulan oligomers, process of its obtaining, and pharmaceutical preparations on the basis of the complex
ZA200203294B (en) N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them.
AU2281601A (en) Treatment of viral infections using levovirinTM
AU1916601A (en) Oncolytic combinations for the treatment of cancer
AU2067501A (en) Human oxidoreductase proteins
AU5547000A (en) Novel treatment
AU1916501A (en) Oncolytic combinations for the treatment of cancer
MXPA01011720A (en) Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods.
AU4556800A (en) Novel treatment
AU4259299A (en) New sequences of tt viruses for use in diagnosis, prevention and treatment of ttv infections
ZA200205470B (en) Virus strains for the oncolytic treatment of cancer.
AU1923501A (en) Pyridinones to treat and prevent bacterial infections
AU1595001A (en) Oncolytic combinations for the treatment of cancer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase